Pharma & Biotech

In a strategic move to strengthen its leadership team, Redcare Pharmacy has recruited a senior Amazon executive to helm its...

A patient death in a key study has triggered a severe downturn for Intellia Therapeutics, with the gene-editing company's stock...

IO Biotech witnessed a dramatic single-day surge of more than 25% in its share price yesterday. This powerful rally was...

The telehealth provider Hims & Hers finds itself navigating turbulent market conditions. Despite management's confident move to authorize a substantial...

The Danish pharmaceutical giant Novo Nordisk is confronting significant pressure across multiple areas of its business. A failed multi-billion dollar...

The prolonged regulatory battle has reached a critical resolution point, with Illumina commencing its mandated divestiture from GRAIL. This strategic...

Investors are driving substantial gains for Outlook Therapeutics as the company achieves a critical regulatory breakthrough. The catalyst behind this...

A surprising development emerged in mid-November when pharmaceutical giant Pfizer divested 54.7% of its stake in BioNTech, triggering a significant...

The publicly traded journey of G1 Therapeutics has reached its conclusion. The biotechnology firm ceased trading on the NASDAQ effective...

The future of CureVac as an independent entity now rests in shareholders' hands as a decisive vote approaches. Investors will...